
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
On October 1, 2011, Takeda Pharmaceutical Company Limited acquired Nycomed. Through the acquisition, Takeda, the largest pharma company in Asia, broadened its coverage of the global pharmaceutical market, especialy in Europe and emergig markets. More information on http://www.takeda.com. The below information is from before the acquisition: Nycomed is a privately owned global pharmaceutical company with a diversified portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. A range of OTC products completes the portfolio. Its R&D is structured around collaborations. In-licensing and expanding in emerging markets are cornerstones of the companys growth strategy....
Partnerships and licensing,emerging markets,specialty pharmaceuticals,respiratory,gastroenterology,inflammatory diseases,pain,osteoporosis,and tissue management
Takeda pharmaceuticals (formerly nycomed) operates in the Pharmaceutical manufacturing industry.
Takeda pharmaceuticals (formerly nycomed)'s revenue is 11m - 100m
Takeda pharmaceuticals (formerly nycomed) has 501 - 1000 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.